SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.99 |
| Enterprise Value ($M) | -0.87 |
| Book Value ($M) | 6.78 |
| Book Value / Share | 1.51 |
| Price / Book | 0.59 |
| NCAV ($M) | 6.48 |
| NCAV / Share | 1.44 |
| Price / NCAV | 0.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.56 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.91 |
| Current Ratio | 7.91 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.26 |
| Assets | 8.57 |
| Liabilities | 1.78 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Intracoastal Capital, Llc | 4.99 | 21.82 | |
| 13G/A | Reda Joseph | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 748,449 | 2,232,130 | 33.53 | |
| 11,047 | 65,001 | 17.00 | |
| 12,892 | 55,677 | 23.15 | |
| 33,200 | 102,336 | 32.44 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SCLX – Scilex Holding Company | SGMO – Sangamo Therapeutics, Inc. |
| SHPH – Shuttle Pharmaceuticals Holdings, Inc. | SLGL – Sol-Gel Technologies Ltd. |
| SLRX – Salarius Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io